Members
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.
Apply Now Learn More View Core GroupCurrent Members
Name
|
Organization | Country |
|---|---|---|
| Tarek Aboul-Fadl | Medicinal Chemistry, Assiut University | Egypt |
| Ibrahim Abubakar | University College London, MRC Clinical Trials Unit | United Kingdom |
| Zahoor Ahmed | National TB Control Programme | Pakistan |
| Asaad Khalid Ahmed | National Center for Research | Sudan |
| Avishek Anant | Novartis | India |
| Koen Andries | Janssen | Belgium |
| Asghar Arif | TB Association Charsadda Pak | Pakistan |
| Yossef Av-Gay | University of British Columbia | Canada |
| Tanjore Balganesh | CSIR-OSDD | India |
| Lluís Ballell | GlaxoSmithKline Tres Cantos | Spain |
| Cathy Bansbach | Bill & Melinda Gates Foundation | United States |
| Jing Bao | Frontier Biotechnologies, LLC | United States |
| David Barros | GlaxoSithKline | Spain |
| Clifton Barry | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Robert Bates | GlaxoSmithKline | Spain |
| Anthony Baughn | University of Minnesota | United States |
| Edward Berry | SUNY Upstate Medical University | United States |
| Sanjib Bhakta | The Institute of Structural and Molecular Biology, Birkbeck, University of London | United Kingdom |
| Khadar Bhatcha | PSG College of Pharmacy | India |
| William Bishai | Johns Hopkins School of Medicine | United States |
| Gill Black | Sustainable Livelihoods Foundation | South Africa |
| Jonathan Blackburn | University of Cape Town | South Africa |
| Amy Bloom | United States Agency for International Development (USAID) | United States |
| Martin Johan Boeree | PanACEA Consortium and the Radboud University Nijmegen Medical Centre | Netherlands |
| Florence Bordon-Pallier | Sanofi | France |
| Helena Boshoff | National Institutes of Health (NIH) | United States |
| Renaud Boulanger | McGill University | Canada |
| Yap Boum II | Epicentre/MSF | Uganda |
| Jim Boyce | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Barry Bunin | Collaborative Drug Discovery | United States |
| Pere-Joan Cardona | Institut Germans Trias i Pujol (IGTP) | Spain |
| Alexandra Carreau | Sanofi-Adventis R&D | France |
| Allen Casey | Infectious Disease Research Institute (IDRI) | United States |
| Gail Cassell | Infectious Disease Research Institute (IDRI) | United States |
| Kenneth Castro | Emory University | United States |
| Joan A. Cayla | Agència de Salut Pública de Barcelona | Spain |
| Richard Chaisson | Johns Hopkins University Center for TB Research | United States |
| William Chamberlin | Texas Tech University Health Sciences Center | United States |
| Sang Nae Cho | Yonsei University College of Medicine | South Korea |
| Sidharth Chopra | Central Drug Research Institute, Lucknow | India |
| Isabelle Cieren-Puiseux | Sanofi | France |
| Jeffery Cirillo | Texas A&M Health Science Center | United States |
| Polly Clayden | HIV i-Base | United Kingdom |
| Stewart Cole | Institut Pasteur | Switzerland |
| Christopher Cooper | Global Alliance for TB Drug Development (TB Alliance) | United States |
| Michael Cynamon | VAMC, SUNY, Upstate Medical University | United States |
| Kobina Bosumtwi Dadzie | Wiljok Childaid and Health Organization | Ghana |
| Aboubacar Sidiki Daffe | Université Cheikh Anta DIOP | Senegal |
| Mary Ann de Groote | Colorado State University | United States |
| Jurriaan de Steenwinkel | Erasmus MC | Netherlands |
| Oscar Della Pasqua | GlaxoSmithKline | United Kingdom |
| Brigitte Demers | Sanofi | France |
| Neeraj Dhar | École Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
| Andreas Diacon | University of Stellenbosch | South Africa |
| Marcio Dias | University of Sao Paulo | Brazil |
| Thomas Dick | University in New Jersey UMDNJ-New Jersey Medical School | United States |
| Chris Dippel | Peloton Partnering, SP | United States |
| Noroi Doi | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| Martin Dolezal | Charles University in Prague, Faculty of Pharmacy in Hradec Kralove | Czech Republic |
| Valerie Flore Donkeng Donfack | Pasteur Center in Cameroon | Cameroon |
| Andriy Dudnyk | National Medical University of Vinnytsia, Ukraine | Ukraine |
| Carol Dukes Hamilton | Family Health International | United States |
| Ken Duncan | Bill & Melinda Gates Foundation | United States |
| Chris Edlin | iThemba Pharmaceuticals | South Africa |
| Leo Einck | Sequella, Inc. | United States |
| Kolawole Ekanoye | Advocates for Health and Development Initiative | Nigeria |
| Muhammad Farooq | Government of Pakistan | Pakistan |
| Bernard Fourie | University of Pretoria | South Africa |
| Scott Franzblau | Institute for Tuberculosis Research, University of Illinois at Chicago | United States |
| Maria Freire | Foundation for NIH | United States |
| Joel Freundlich | UMDNJ - New Jersey Medical School | United States |
| James Frincke | Hollis Eden Pharmaceuticals | United States |
| Sylvie Garneau-Tsodikova | University of Michigan | United States |
| Lawrence Geiter | Otsuka Pharmaceutical Company | United States |
| Bolin Geng | Ra Pharma | United States |
| Jan Gheuens | Bill & Melinda Gates Foundation | United States |
| Ann Ginsberg | IAVI | United States |
| Marc Gitzinger | BioVersys AG | Switzerland |
| Bob Goldman | RCG Consulting | United States |
| Martin Graham | KinderPharm | United States |
| Hugo Cesar Gramajo | Instituto de Biologia Molecular y Celular de Rosario | Argentina |
| Jacques Grosset | Scientist | France |
| Malgosia Grzemska | World Health Organization (WHO) | Switzerland |
| Tawanda Gumbo | Baylor University | United States |
| Shashank Gupta | Brown University | United States |
| Juan David Guzman | Birkbeck College | United Kingdom |
| Debra Hanna | Bill and Melinda Gates Foundation | United States |
| Nii Nortey Hanson-Nortey | Ghana Health Service | Ghana |
| Mark Harrington | Treatment Action Group | United States |
| Norbert Heinrich | Universtiy of Munich / PanACEA | Germany |
| Sonja Henne | MSF | Tunisia |
| Anneke Hesseling | Desmond Tutu TB Centre | South Africa |
| Philip Hipskind | Lgenia | United States |
| Michael Hoelscher | Ludwig-Maximilians-University | Germany |
| C. Robert Horsburgh | Boston University School of Public Health | United States |
| Gary Horwith | BARDA | United States |
| Robert Husson | Children's Hospital Boston/Harvard Medical School | United States |
| Daniela Jabes | NeED Parma | Italy |
| Mary Jackson | Colorado State University | United States |
| Josef Jampilek | Comenius University | Slovakia |
| Amina Jindani | St. George's, University of London | United Kingdom |
| KR John | SRM Medical College | India |
| Yadav Prasad Joshi | Biodyss and Journal Infection in Developing Countries | France |
| Rajender Kamboj | Lupin Limited | India |
| Bavesh Kana | University of the Witwatersrand/National Health Laboratory Service | South Africa |
| Takushi Kaneko | TB Alliance | United States |
| Shashi Kant | UT Southwestern Medical Center | United States |
| Gilla Kaplan | United States | |
| Petros Karakousis | Johns Hopkins University School of Medicine | United States |
| Victoria Kasprowicz | SANTHE | South Africa |
| Hiromu Kawakubo | Asahi Kasei Chemicals Corporation | Japan |
| Ahmadul Khan | Ahmadul Hasan Khan | Bangladesh |
| Basharat Khan | National TB Control Programme | Pakistan |
| Sang Jae Kim | Korean Institute of Tuberculosis | South Korea |
| Sergey Koren | JSC Pharmasyntez | Russia |
| Anil Koul | Johnson and Johnson | Belgium |
| Galyna Kutsyna | Luhansk State Medical University | Ukraine |
| Gyanu Lamichhane | Johns Hopkins University | United States |
| Barbara Laughon | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Didier Leboulleux | Sanofi | France |
| Anne Lenaerts | Colorado State University | United States |
| Erica Lessem | Treatment Action Group | United States |
| Francisco Leyva | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Christian Lienhardt | World Health Organization (WHO) | Senegal |
| Christopher Locher | Baxalta | United States |
| Nino Lomtadze | National Center for Tuberculosis and Lung Diseases | Georgia |
| James Love | Knowledge Ecology International (KEI) | United States |
| Doug Lowrie | Fudan University's Shanghai Public Health Clinical Center | China |
| Shichun Lun | Johns Hopkins University School of Medicine | United States |
| Htay Lwin | National TB Program, Myanmar | Myanmar (Burma) |
| Parameshwar Makam | University of KwaZulu-Natal | South Africa |
| Mamodikoe Makhene | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Alick Chimpimo Makiyi | Grassroots Movement for Health and Development (GMHD) | Malawi |
| Albert Makone | Community Representative; Global Fund (local) | Zimbabwe |
| Teto Fondacaro Mamona | Programme National de Lutte Contre la Tuberculose | Democratic Republic Of Congo (Zaire) |
| Shekhar Mande | National Centre for Cell Science | India |
| Bonita Mangura | Global TB Institute at UMDNJ | United States |
| Mohammad Hassan Mashori | Fundamental Human Rights & Rural Development Association (FHRRDA) | Pakistan |
| Stephen Matlin | Global Forum for Health Research | Switzerland |
| Maggie McCammon | Michigan Economic Development Corporation | United States |
| David McNeeley | Medical Service Corportation International (MSCI) | United States |
| Khisimuzi Mdluli | Bill and Melinda Gates Medical Research Institute | United States |
| Arun Kumar Mishra | University of Birmingham | United Kingdom |
| Carole Mitnick | Harvard Medical School | United States |
| Valerie Mizrahi | UCT-Institute of Infectious Disease and Molecular Medicine | South Africa |
| Heinz Moser | Achaogen | United States |
| Roger Moses | iThemba Pharmaceuticals | United Kingdom |
| Ute Muh | University of Iowa | United States |
| Benson Muriuki | Center for the Empowerment Of The Local Herbalist-Celoh Kenya | Kenya |
| Carol Nacy | Sequella, Inc. | United States |
| Payam Nahid | University of California, San Francisco | United States |
| P. R. Narayanan | Tuberculosis Research Centre, Chennai (retired) | India |
| Edward Nardell | Partners in Health | United States |
| Carl Nathan | Weill Cornell Medical College | United States |
| Michaela Nielsen | Regulatory Affairs Consultant | United States |
| Eric Nuermberger | Johns Hopkins University | United States |
| Rick O'Brien | Switzerland | |
| Ronan O'Toole | Trinity College Dublin | Ireland |
| Dorothy Odhiambo | International Community of Women Living with HIV in Kenya ( ICW-K) | Kenya |
| Masaji Okada | Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center | Japan |
| Iain Old | Innovative Medicines for TB (iM4TB) | Switzerland |
| Abdifetah Ibrahim Omer | National TB Programme Somalia | Somalia |
| Philip Onyebujoh | WHO Regional Office for Africa | Zimbabwe |
| Diane Ordway | Colorado State University | United States |
| Regina Osih | Clinton Health Access Initiative | South Africa |
| Nelson Otwoma | Positive Familes Network (+FN) | Kenya |
| Prasit Palittapongarnpim | Mahidol University | Thailand |
| Rogelio Hernandez Pando | National Institute of Medical Sciences and Nutrition, Mexico | Mexico |
| Frances Pappas | TB Alliance | United States |
| Shreemanta Parida | Clinical Scientist | India |
| Tanya Parish | Infectious Disease Research Institute (IDRI) | United States |
| Prasad Pasam | Shar Technologies Group | India |
| Fernando Pavan | Sao Paulo State University, UNESP, Brazil | Brazil |
| Liyanage Perera | National Institutes of Health (NIH) | United States |
| Kevin Pethe | Institut Pasteur-Korea | South Korea |
| Matthew Price | Harvard School of Public Health | United States |
| Marina Protopopova | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Dhanji Rajani | Microcare Laboratory | India |
| Ravishankar Ramachandran | CSIR-Central Drug Research Institute, Lucknow, India | India |
| Santiago Ramón García | Research Agency of Aragon (ARAID) | Spain |
| Kanury Rao | International Centre for Genetic Engineering & Biotechnology-New Delhi | India |
| Mario Raviglione | Università degli Studi di Milano | Switzerland |
| Klaus Reither | Swiss Tropical and Public Health Institute | Tanzania |
| Kyu Rhee | Weill Cornell Medical College | United States |
| Brian Robertson | Imperial College London | United Kingdom |
| Doris Rouse | RTI International | United States |
| Samir Roy | Government Medical College, Bhavnagar | India |
| David Russell | Cornell University | United States |
| Sandeep Saluja | No affiliation | India |
| Roberto Salvino | No affiliation | Philippines |
| Christopher Sassetti | University of Massachusetts Medical School | United States |
| Kampasati Satyanarayana | Yuvabharath Society | India |
| Dario Scaramuzzi | R-Evolution Group EEIG | Italy |
| Dirk Schnappinger | Weill Cornell Medical College | United States |
| Cherise Scott | TB Alliance | United States |
| Boitumelo Semete | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| David Sherman | University of Washington | United States |
| Tado Shimao | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| Christine Sizemore | Fogarty International Center at NIH | United States |
| Nelly Solomonia | National Center for Tuberculosis and Lung Diseases | Georgia |
| Melvin Spigelman | TB Alliance | United States |
| Martin Springsklee | Bayer Healthcare | United States |
| Hulda Swai | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| John Szumowski | Santa Clara Valley Medical Center | United States |
| Rajneesh Taneja | TB Alliance | United States |
| Gail Tauscher | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Simon Tiberi | Barts Healthcare NHS Trust | United Kingdom |
| Tamari Trapaidze | Welfare Foundation | Georgia |
| Oleg Tsodikov | University of Kentucky | United States |
| Manjunatha Ujjini | Novartis Institute for Tropical Diseases | Singapore |
| Anna Upton | TB Alliance | United States |
| Astrid Van der Sar | VU University Medical Center | Netherlands |
| Christo van Niekerk | TB Alliance | South Africa |
| Omar Vandal | Bill and Melinda Gates Foundation | United States |
| Brian VanderVen | Cornell University | United States |
| Wim Vandevelde | European AIDS Treatment Group (EATG); Community Representative | South Africa |
| Gustavo E. Velásquez | University of California, San Francisco | USA |
| Andrew Vernon | U.S. Centers for Disease Control and Prevention (CDC) | United States |
| Laura Via | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Dalene von Delft | TB Proof | South Africa |
| Todd Waldman | Easton Associates | United States |
| Kristina Wallengren | THINK | South Africa |
| Robert Wallis | Aurum Institute | South Africa |
| Gerhard Walzl | Stellenbosch University | South Africa |
| Joshua Wamboga | Uganda Network of AIDS Service Organisations (UNASO) | Uganda |
| Steve Wandiga | KEMRI/CDC | Kenya |
| Tiansheng Wang | Vertex Pharmaceuticals | United States |
| Peter Warner | Bill and Melinda Gates Foundation | United States |
| Charles Wells | Sanofi | United States |
| Richard White | London School of Hygiene and Tropical Medicine | United Kingdom |
| Nicolas Willand | Institut Pasteur Lille | France |
| Sharon Williams | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Claire Wingfield | PATH | United States |
| Jerome Zeldis | Celgene | United States |
| Ying Zhang | Johns Hopkins University | United States |
| Xuelian Zhang | Fudan University | China |
| Oren Zimhony | Kaplan Medical Center, The School of Medicine Hebrew University | Israel |
| Daniel Zollinger | QareFree | Netherlands |
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us